Compare Gunung Raja Paksi Tbk. (GGRP) vs UBC Medical Indonesia Tbk. (LABS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Gunung Raja Paksi Tbk. vs UBC Medical Indonesia Tbk. — how do they compare? Gunung Raja Paksi Tbk. trades at Rp294 (market cap 3.58T, 527.5K 24h volume), while UBC Medical Indonesia Tbk. trades at Rp147 (market cap 576.7B, 3.18M 24h volume). The key difference: Gunung Raja Paksi Tbk. is far larger — about 6.2× UBC Medical Indonesia Tbk.'s market cap, and UBC Medical Indonesia Tbk. is more actively traded (3.18M versus 527.5K). Which is the better fit depends on your goals.
| GGRP | LABS | |
|---|---|---|
Market Cap | 3.58T | 576.7B |
Volume | 527.5K | 3.18M |
Lot | 5.28K | 31.76K |
Turnover | 154.61M | 477.6M |
Average Price | 293.1 | 150.39 |
Value | 154.61M | 477.6M |
Indicative Equilibrium Price | 296 | 147 |
Indicative Equilibrium Volume | 300 | 311 |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Gunung Raja Paksi Tbk.
PT. Gunung Raja Paksi Tbk (the Company) was established under the name of PT Gunung Naga Mas based on Notarial Deed No.229 of Chairani Bustami,S.H. dated August 20,1990 that was amended by Notarial Deed No.25 dated June 6,1991. The change from Foreign Capital Investment (“FCI”) to Domestic Capital Investment (“DCI”) has been approved by the Capital Investment Coordinating Board of the Republic of Indonesia in its Letter No.346/1/IP/PMDN/2016 dated December 15, 2016.
Read more on GGRP →About UBC Medical Indonesia Tbk.
PT UBC Medical Indonesia (the Company) was established under the framework of Law of the Republic of Indonesia No. 20 year 1994 concerning the Foreign Capital Investment, as amended by Law No. 25 year 2007 concerning the Capital Investment based on Notarial Deed No. 01 dated 4 June 2014 of Novita Puspitarini, S.H., Notary in Jakarta. The Company started its commercial activities in October 2014. The parent entity as well as the ultimate parent entity of the Company is PT Optel Investama Mulia.
Read more on LABS →
